Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease

Lancet

Volumn 353, Issue 9166, 1999, Pages 1764-1765

  Merims, Doron ^b   Ziv, Ilan ^b   Djaldetti, Ruth ^b   Melamed, Eldad ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMINOTRANSFERASE; DEXTROMETHORPHAN; DOPAMINE; GLUTAMATE RECEPTOR ANTAGONIST; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RILUZOLE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HOME MONITORING; HUMAN; MALE; NAUSEA; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0033594792     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00120-8     Document Type: Article

References (5)

1. Marsden CD. Problems with long-term levodopa therapy for Parkinson's disease. Clin Neuropharmacol 1994; 17 (suppl 2): S32-44.
2. Krack P, Pollal P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121: 451-57.
3. Verhagen Metman L, Del Dotto P, van den Munckoof P, et al. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Neurology 1998; 51: 203-06.
4. Verhagen Metman L, Del Dotto P, Natte R, et al. Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease. Neurology 1998:203-06.
5. Bensimon G, Lamcoblez L, Meninger V, and the ACR/riluzole study group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-91.